My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 107

1.

Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.

Soumittra N, Meenakumari B, Parija T, Sridevi V, Nancy KN, Swaminathan R, Rajalekshmy KR, Majhi U, Rajkumar T.

Hered Cancer Clin Pract. 2009 Aug 6;7(1):13.PMID: 19656415 [PubMed]Related articlesFree article

2.

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

J Biosci. 2009 Sep;34(3):415-22.PMID: 19805903 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases.

Syamala V, Syamala VS, Sreeja L, Raveendran PB, Vijayalekshmi RV, Sheeja VR, Santhi S, Kuttan R, Abraham EK, Ankathil R.

J Exp Ther Oncol. 2008;7(3):227-36.PMID: 19066131 [PubMed - indexed for MEDLINE]Related articles

4.

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.

Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S, Sera F, Palli D.

Breast Cancer Res Treat. 2009 Aug;116(3):577-86. Epub 2008 Sep 26.PMID: 18819001 [PubMed - indexed for MEDLINE]Related articles

5.

German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.

Rashid MU, Jakubowska A, Justenhoven C, Harth V, Pesch B, Baisch C, Pierl CB, Brüning T, Ko Y, Benner A, Wichmann HE, Brauch H, Hamann U; GENICA Network.

Eur J Cancer. 2005 Dec;41(18):2896-903. Epub 2005 Oct 18.PMID: 16239104 [PubMed - indexed for MEDLINE]Related articles

6.

Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.

Byrd LM, Shenton A, Maher ER, Woodward E, Belk R, Lim C, Lalloo F, Howell A, Jayson GC, Evans GD.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1535-42.PMID: 18559571 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer.

Skasko E, Kluska A, Niwińska A, Kwiatkowska E, Bałabas A, Piatkowska M, Dabrowska M, Nowakowska D, Pieńkowski T.

Onkologie. 2009 Apr;32(4):182-8. Epub 2009 Mar 13.PMID: 19372713 [PubMed - indexed for MEDLINE]Related articles

8.

Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.

Evans DG, Young K, Bulman M, Shenton A, Wallace A, Lalloo F.

Clin Genet. 2008 Apr;73(4):338-45. Epub 2008 Feb 26.PMID: 18312450 [PubMed - indexed for MEDLINE]Related articles

9.

Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia.

Budroni M, Cesaraccio R, Coviello V, Sechi O, Pirino D, Cossu A, Tanda F, Pisano M, Palomba G, Palmieri G.

BMC Cancer. 2009 Feb 20;9:62.PMID: 19232099 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.

De Silva W, Karunanayake EH, Tennekoon KH, Allen M, Amarasinghe I, Angunawala P, Ziard MH.

BMC Cancer. 2008 Jul 29;8:214.PMID: 18662409 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.

Palomba G, Loi A, Uras A, Fancello P, Piras G, Gabbas A, Cossu A, Budroni M, Contu A, Tanda F, Farris A, Orrù S, Floris C, Pisano M, Lovicu M, Santona MC, Landriscina G, Crisponi L, Palmieri G, Monne M.

BMC Cancer. 2009 Jul 20;9:245.PMID: 19619314 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG.

Int J Gynecol Cancer. 2006;16 Suppl 2:552-5.PMID: 17010071 [PubMed - indexed for MEDLINE]Related articles

13.

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.

Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J, Brooks KA, Cohen S, Tenenholz B, Desai D, Zandvakili I, Royer R, Li S, Narod SA.

BMC Cancer. 2009 Mar 19;9:86.PMID: 19298662 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer.

Diez O, Gutiérrez-Enríquez S, Mediano C, Masas M, Saura C, Gadea N, Balmaña J.

Breast Cancer Res Treat. 2009 Aug 1. [Epub ahead of print]PMID: 19649703 [PubMed - as supplied by publisher]Related articles

15.

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.

Suspitsin EN, Sherina NY, Ponomariova DN, Sokolenko AP, Iyevleva AG, Gorodnova TV, Zaitseva OA, Yatsuk OS, Togo AV, Tkachenko NN, Shiyanov GA, Lobeiko OS, Krylova NY, Matsko DE, Maximov SY, Urmancheyeva AF, Porhanova NV, Imyanitov EN.

Hered Cancer Clin Pract. 2009 Feb 25;7(1):5.PMID: 19338682 [PubMed]Related articlesFree article

16.

[Analysis of BRCA1 gene mutations in patients with early-onset breast cancer and their affected relatives in Guangdong province]

Zhou J, Rao NY, Li SR, Jin L, Jia WJ, Gong C, Yu FY, Su FX, Song EW, Shao ZM.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Feb;29(2):213-6. Chinese. PMID: 19246281 [PubMed - in process]Related articlesFree article

17.

The contribution of BRCA1 and BRCA2 to ovarian cancer.

Ramus SJ, Gayther SA.

Mol Oncol. 2009 Apr;3(2):138-50. Epub 2009 Feb 10. Review.PMID: 19383375 [PubMed - indexed for MEDLINE]Related articles

18.

Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country.

Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH.

World J Surg. 2009 Oct;33(10):2077-81.PMID: 19649760 [PubMed - indexed for MEDLINE]Related articles

19.

CHEK2 1100delC and male breast cancer in the Netherlands.

Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG, Meijers-Heijboer H, Foekens JA, Schutte M.

Breast Cancer Res Treat. 2009 Jul;116(2):397-400. Epub 2008 Aug 31.PMID: 18759107 [PubMed - indexed for MEDLINE]Related articles

20.

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.

Armaou S, Pertesi M, Fostira F, Thodi G, Athanasopoulos PS, Kamakari S, Athanasiou A, Gogas H, Yannoukakos D, Fountzilas G, Konstantopoulou I.

Br J Cancer. 2009 Jul 7;101(1):32-7. Epub 2009 Jun 2.PMID: 19491894 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed
Write to the Help Desk